Good evening, everyone, and thank you for joining today's FIGS third quarter fiscal 2022 earnings conference call. My name is Dante, and I'll be your operator for today's call. All lines will be muted during the presentation portion of today's call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone keypad. I would now like to pass the conference over to our host, Ms. Jean Fontana, Head of Investor Relations. Ma'am, the floor is now. Thank you. Good afternoon, and thank you for joining today's call to discuss FIGS third quarter 2022 results, which we released this afternoon and can be found in our earnings press release and in the stockholder slide deck on our investor relations website at ir.wearfigs.com. Presenting on today's call are Trina Spear, our Co-Founder and Chief Executive Officer, and Daniella Turenshine, our Chief Financial Officer. As a reminder, remarks on this call that do not concern past events are forward-looking statements. These may include predictions, expectations, or estimates, including about future financial performance, market opportunity, or business plans. Forward-looking statements involve risks and uncertainties, and actual results could differ materially. These and other risks are discussed in our SEC filings, including in the 10-Q filed today, which we encourage you to review. Do not place undue reliance on forward-looking statements, which speak only as of today and which we undertake no obligation to update. Finally, we will discuss certain non-GAAP metrics, which we believe are useful supplemental measures for understanding our business. Reconciliations of these non-GAAP measures to their most comparable GAAP measures are included in the earnings release and shareholder deck we issued today. Now I'd like to turn the call over to Trina Spear, Chief Executive Officer of FIGS. Thank you, Jean. Good afternoon, everyone. Thank you for joining us for our third quarter 2022 conference call. I wanna thank the entire FIGS team for their hard work and devotion to the healthcare community. We delivered strong financial performance for the third quarter, with net revenue growth of 25% year-over-year, gross margin over 70%, and adjusted EBITDA margin of 16.4%. Our performance was led by a focused effort to expand our community, which grew our active customers by 24% to 2.2 million on an LTM basis. This is the second highest number of new customers of any quarter in FIGS' history. We also delivered a record level of customer reactivation, defined as customers who have lapsed for 12 months and have since returned to FIGS. Looking at average order value, or AOV, we delivered 10% growth year-over-year as we continued to emphasize our complete layering system with the expansion of our lifestyle offerings. Lifestyle generated sales growth of 65% in the quarter and reached 17% of net revenue. Net revenues per active customer also increased, up $8 from last year. Finally, our international business delivered strong performance with a 49% increase in net revenue. While many of our key operating metrics showed strong performance, our frequency rates continued to slow. These softer trends became more pronounced toward the end of September and quarter to date. We attribute this to two factors. First, we believe the macro trends, including the sustained level of inflation, began to weigh more heavily on our healthcare professionals. Our own customer surveys tell us that FIGS remains their favorite brand, but they are pulling back on purchases due to their tighter budget. Secondly, recent color launches did not generate the same sales lift we have typically seen in the past. We expect these trends to continue through the remainder of the quarter, and therefore, we are reducing our outlook. While we can't control the macro headwinds, we can control how we drive our business forward. We're adjusting to the macro conditions, listening to our healthcare professionals, and focusing on product innovation to meet their needs. Our deep connection with healthcare professionals fuels our drive to continuously evolve our business and bring excellence to our community. We will continue to make strategic investments to advance our leadership position in the healthcare apparel industry while carefully managing costs through the challenging period. Turning to our strategic priorities, starting with product innovation. As we've discussed in the past, our product innovation strategy is focused on both our scrubs business and our lifestyle offerings, which together make up our layering system. By leveraging the insights and data we receive from the healthcare community, we continue to improve at creating products with the feature and design solutions our customers want most. We will continue to lean into our solutions-based approach as we develop even more new products that are technical, comfortable, and functional while continuing to incorporate new colors which drive both loyalty and new customer acquisition. We believe this more holistic approach to style and color launches will amplify excitement around newness. This approach has already demonstrated tremendous success in launching our cargo collection, where we highlighted the functionality and comfort of products in new colors. In our scrubs business, we continue to expand our selection with the innovation and product enhancements our customers are looking for. For example, our Rafaela scrub jumpsuit in quartz sold out within hours during our breast cancer awareness campaign. As a result of the strong demand, we expect to add this jumpsuit to our core offering. Our lifestyle offerings have continued to drive growth in net revenues per active customer, mainly through lift in UPT, as customers look to purchase the layering system. This has helped fuel the growth in AOV, which has increased 18% from $95 in 2019 to an LTM average of $112. This purchasing dynamic continued into the third quarter, with orders including lifestyle offerings reflecting a more than 30% higher UPT on average than purchases without. The strength of our lifestyle offerings also illustrates our ability to grow our TAM. We were encouraged to see the double-digit lift in first orders that contain lifestyle offerings as we continue to deliver innovation that addresses the broader needs of healthcare professionals. A great example of how lifestyle attracts new customers is FIGSPRO. This polished and performance-driven office-ready collection launched earlier this year with excellent results. Our expanded collection is resonating with physicians and dentists, entering the FIGS community and driving a positive response from our loyal customers. As we look ahead, we expect to introduce an even greater flow of new products as we continue to identify gaps and pain points in our customers' uniforms. We are also expanding our scrubwear fabric portfolio and developing new techniques within our existing fabrications to solve more use cases and style options. Within lifestyle, we will continue to expand our offerings across categories. For example, we are building on the success of our outerwear business, where we have seen strong demand for our on-shift styles. Previously, healthcare professionals bought fleeces from traditional brands, which were not constructed with the healthcare professional's needs in mind. We deliver an alternative with outstanding quality and functionality that meets their needs. We recently launched our new lightweight packable puffer, perfect for cold shifts requiring warmth, lightness, and mobility. Our puffer can be worn on and off shift, giving our customers greater versatility. We are also excited to be soft launching extended sizes, ranging from 3XL to 6XL later this year. This is great news for our community. We are responding to a large and underserved segment of the healthcare community that has shared their desire to wear FIGS. Fit is a critical component in the success of our brand, and we have been working diligently to optimize our fit for extended sizes to ensure the best possible experience for our healthcare professionals. Moving next to building brand awareness. With just over 2 million active customers in the U.S. at the end of Q3, we have penetrated approximately 10% of U.S. healthcare professionals and continue to see a significant growth opportunity. As I mentioned, we added the second highest number of new customers of any quarter in FIGS' history, despite the challenging macro environment. We invested in digital marketing during the quarter to drive new customer acquisition, particularly within our social media channels. We continue to leverage multiple digital and out-of-home outlets to share brand moments and educate healthcare professionals about our mission and our purpose. We plan to lean further into YouTube, TikTok, and OTT, where we will be tailoring our creative to align with varying audiences and channels. Looking at out-of-home, we launched our Philadelphia activation in August. This included a three-day in-person event near Thomas Jefferson University and other hospitals. We were excited to see the strong turnout as healthcare professionals took the opportunity to see our new offerings in person and touch and feel our products. This quarter, we also continued to deliver brand moments on topics we know are very important to our healthcare community. For Breast Cancer Awareness Month, we launched our Peace Out breast cancer campaign, highlighting our limited edition quartz color. As part of our commitment to the healthcare community, we donated $50,000 to Memorial Sloan Kettering Cancer Center to support their Young Woman with Breast Cancer program. For the holidays, we plan to launch our integrated gift-giving campaign across multiple social channels, allowing everyone to gift FIGS to express their gratitude to the healthcare professionals in their lives. We expect #GiftFIGS to be the biggest gifting movement in our history, with influencers and celebrities sharing inspiring stories with a call to action as they give back to their awesome humans. We also plan to incorporate this campaign into our Chicago activation at the Magnificent Mile in Millennium Park, which is happening right now. To lead our marketing efforts, I'm pleased to share that we appointed Sunil Kaki as Chief Marketing Officer. With his proven track record in building brands and communities and deep digital marketing knowledge, we are excited to have him lead our marketing strategy. Let's turn now to customer engagement, where we continue to look for ways to elevate the experience for our loyal community. We recently launched a new customized mobile app that we developed to drive more meaningful engagement with our healthcare community. The features of our new mobile app extend well beyond enhancing the purchase experience, enabling us to connect more deeply with our healthcare community through more relevant educational content, personalization, and wellness support. This launch is another way to raise the bar on how we serve our awesome humans. At FIGS, we remain committed to supporting this incredible community through advocacy. As part of this effort, we took nine leading healthcare professionals to Washington, D.C., in September to advocate for comprehensive legislation, which we call the Awesome Humans Bill, to reduce the burden and strain on our community. There are many issues to address, including pay, mental health, safety, and training. We met with 17 congressional offices on Capitol Hill and the White House to move this conversation forward. In addition to our many other philanthropy efforts, advocacy at FIGS will continue to be an important way that we deliver for our healthcare professionals. Finally, let me talk about international, and I'll start by saying that we are very pleased with our progress in growing our nascent international presence. As we discussed on our last call, we took steps to improve the customer experience and lower barriers to conversion in international markets. These efforts supported revenue growth of 49%, with particularly strong performance in Canada, U.K., and the European markets we've entered. As we focus on driving brand awareness internationally, we expect to enhance the customer experience through language translations and dedicated marketing support. In addition, we plan to launch localized marketing campaigns to engage with the community and elevate the customer experience through tailored messaging. We're highly encouraged by the growing demand for the FIGS brand globally. As a capital-light D2C business, we can enter markets relatively quickly. Thus far, in the fourth quarter, we have entered New Zealand, Israel, and the UAE. We plan to opportunistically expand as we seek to gain the first mover advantage, focusing on the countries where we see demand for FIGS. While we expect the macro environment to remain challenging in the near term, we intend to invest strategically in our long-term growth while carefully managing our costs. We believe this will best position us to deliver consistent and profitable growth over the long term, especially once the macro dynamics improve. With that, let me turn it over to Daniella. Thanks, Trina, and good afternoon, everyone. I will begin with a review of our third quarter performance and discuss our revised outlook. For the third quarter, net revenues grew 25% to $129 million, compared to $103 million in Q3 last year, primarily due to an increase in orders from existing and new customers and, to a lesser degree, higher AOV. We were pleased to deliver a 24% increase in active customers, fueled by ongoing initiatives to drive brand awareness globally and strong reactivation among lapsed customers. AOV grew 10%, led by higher units per transaction, or UPT, and an increase in average unit retail, or AUR. Both UPT and AUR benefited from the continued strong response to our lifestyle offerings, reflecting the power of our layering system. Orders containing a lifestyle product reflected a 30% higher UPT than those without. To a lesser degree, promotional events in the quarter also drove higher UPT. The higher AOV on an LTM basis drove net revenue per active customer to $227, up $8 from Q3 last year. While we delivered strong performance across key operating metrics in Q3, based on more recent trends in purchase frequency, we believe the impact of the macro environment on our customer base is increasing. In addition, as Trina stated, revenue from color launches did not meet our expectations. As a result, we are taking steps to increase the velocity of our product innovation strategy and take a more holistic approach to new styles and colors. Gross margin for Q3 was 70.6%, compared to 72.7% in Q3 2021. The 70.6% was above our expectations due to lower than expected freight costs. The 210 basis point decline compared to Q3 last year was primarily due to increased freight costs resulting from higher air freight usage and an increase in ocean freight rates. To a lesser extent, we also saw an impact from the higher mix of promotions and product mix. Moving to operating expenses. Selling expense for Q3 was $31.9 million, representing 24.8% of net revenues, compared to 19.4% in Q3 2021. This was primarily due to higher costs within fulfillment, including warehouse storage necessary to house inventory we pulled forward. To a lesser degree, selling expense was also impacted by higher shipping rates. Marketing expense for Q3 was $20 million, representing 15.6% of net revenues, compared to 15.4% in Q3 2021. As Trina mentioned, we made investments in digital, where we saw opportunities to drive new customer acquisition. We also increased our out-of-home marketing spend as we tested ways to expand brand awareness. Consistent with what we have shared in the past, we are able to maintain healthy customer acquisition costs due to the effectiveness of word of mouth, which continues to be the number one driver of new customers. We are highly focused on positive first order contribution margin, and that discipline has not changed. At 2.2 million active customers, we have significant untapped potential in the U.S. alone, and we are on a mission to be the largest provider of scrubs and lifestyle apparel to the healthcare community. With that as our North Star, we believe that balancing investments in top of funnel marketing and maintaining a first order profitable discipline is the right approach to growing our brand in a healthy way. G&A expense for Q3 was $27.7 million, representing 21.5% of net revenues, compared to 27.7% in Q3 2021. Of the 620 basis point decrease, 190 basis points is due to a change in our accrual methodology for charitable donations. Additionally, G&A benefited from reimbursements of legal fees totaling $5 million. However, this was partially offset by increased public company costs associated with implementing Sarbanes-Oxley Section 404. Taking this to the bottom line, our net income was $4 million or $0.02 in diluted EPS for the quarter. Adjusted net income was $4.1 million, and diluted EPS, as adjusted, was $0.02 in Q3. This compares to adjusted net income and diluted EPS, as adjusted, of $9.4 million and $0.05 per share in Q3 2021, respectively. Finally, our adjusted EBITDA for Q3 remained strong at $21 million, for an adjusted EBITDA margin of 16.4% compared to 21.6% in Q3 2021. Touching on our balance sheet. We finished the quarter with cash and cash equivalents of $155.6 million. Inventory totaled $168.1 million at the end of the third quarter. As we discussed on our second quarter call, given the supply chain challenges we experienced in the first half of the year, we decided to increase weeks of supply on our core styles to ensure we could adequately fulfill customer demand. Furthermore, we decided to bring in limited edition colors and styles earlier to support the planned launches. As a result, we saw inventory build through the quarter as shipments came in even earlier than planned. As a result, in-transit made up 24% of inventory, down from approximately 30% at the end of Q2. Breaking down inventory on hand, the composition looks similar to Q2. Over 50% is in core styles and colors, which carries less obsolescence risk due to our uniform product seasonless, always in stock nature. Approximately 20% is in future colors and styles that we pulled in early, as I mentioned above. We will work diligently to get inventory back in line. We have updated our future core purchase orders in order to bring down our weeks of supply over time. In addition, we are taking action through promotional strategies to move through inventory from prior launches. We believe these measures will enable us to get inventory growth more aligned with sales growth by mid-2023. The key priority is to maintain healthy inventory levels to optimally manage our working capital and maintain our strong debt-free balance sheet. Moving to our outlook, I'd like to provide more context on what we expect for the fourth quarter and touch on some expectations for next year based on recent trends and initiatives we have in place. Starting with the top line, we expect fourth quarter net revenue growth to be in the mid-single-digit range. This assumes that strong growth in active customers will be partially offset by a continuation of lower frequency rates, and a slightly lower than previously expected AOV versus last year. With respect to frequency rate, we expect customer demand will continue to be impacted by the challenging macro environment. In addition, we expect the sales lift from color launches to remain in line with more recent trends, especially as we lack record-breaking color launches last year. Turning to average order value. While we had anticipated a deceleration in growth due to the tougher AOV comparison of $113 in Q4 last year, we now expect to see further pressure due to deeper promotions as we work through inventory from past color launches. While we expect more sales to come from promotions given the current macro environment, we are committed to maintaining discipline in our promotional activity, even if that means lower growth in the short term. We recognize that the holiday period will be highly promotional, which is what customers are gravitating to. However, we are managing our business for long-term success and prioritizing maintaining brand integrity. Moving to gross margin. As mentioned earlier, freight rates have sequentially improved. However, we expect this to be offset by deeper promotions versus last year. Therefore, our outlook for gross margin remains unchanged for the fourth quarter. Looking at operating expenses. Starting with selling expense, we expect greater deleverage than we saw in Q3 due to a full quarter of expenses related to the storage of additional inventory and the continuation of higher shipping costs. These elevated costs are expected to extend into the first half of 2023 while we take action to reduce inventory levels. Additionally, starting in Q1 2023, as we scale our business for future growth, we plan to make enhancements to our fulfillment capabilities to increase reliability and flexibility and shorten fulfillment times to elevate the customer experience. We expect marketing expense as a percentage of sales to be similar to Q3 as we continue to drive brand awareness initiatives which have a longer ROI time horizon than performance marketing. For the full year, we now expect marketing to be slightly above 15% as we opportunistically accelerated spending in new customer acquisition where we saw an attractive return. As we look ahead to 2023, we remain committed to maintaining a positive first order contribution margin and expect marketing to remain around 15% of net revenues. On G&A, we expect costs to increase as a percentage of sales for the fourth quarter due to an increase in our accrual for future donations of inventory and additional costs for SOX implementation. In 2023, we plan to make strategic investments in international expansion and product innovation as we continue to drive growth in the business. Turning to our revised 2022 guidance. As a result of these factors, we now expect net revenues to be approximately $495 million, representing growth of 18% compared to 2021. Our 2022 full year adjusted EBITDA margin is now expected to be approximately 16%. In conclusion, we remain committed to delivering both the product innovation and deep engagement that our healthcare community has come to rely on. We plan to manage our business prudently through the macro environment while continuing to advance our growth strategies across product innovation, international expansion, and fulfillment capabilities. We believe the investments we are making today set us up to be an even stronger company as we emerge from this challenging period, and we have a healthy balance sheet to support these initiatives as we scale our business for sustainable and long-term profitable growth. With that, I will turn it over to the operator to kick off our Q&A session, first with our analyst community addressing their questions. We will then answer questions received from our shareholders through the Say platform. Operator? Thank you, ma'am. If you would like to ask a question, please press star followed by one on your telephone keypad. If for any reason you would like to remove that question, please press star followed by two. Again, to ask a question, it is star one. As a reminder, if you're using a speakerphone, please remember to pick up your handset before asking your question. We will pause here briefly as questions are registered. Our first line of questions comes from the line of Brian Nagel with Oppenheimer. Your line is now open. Hi, good evening. Thanks for taking my questions. I guess my first question, I mean, maybe a simple one, just with respect to the updated guidance, and particularly Q4. What you laid out for Q4, that mid-single-digit growth, is that consistent with what you're seeing in the business right now? Looking at Q4, approximately half of that deceleration is coming from a decrease in frequency. Our forecast for the fourth quarter reflects the trends that we're seeing at the end of September and also quarter to date. As we look at our data, we do believe that healthcare professionals are still grappling with inflation and looking for ways to stretch their dollar further. The remainder is related to AOV, which we initially expected would be up slightly year-over-year, as we're lapping an AOV of $113 in the fourth quarter of last year, which we do believe was partially fueled by stimulus spending. Our outlook now for Q4 reflects slightly lower AOV year-over-year. While we are anticipating higher UPT, we do expect that to be offset by lower AUR, given higher discount rates that we're planning to do in Black Friday, Cyber Monday. As a reminder, 2021 Black Friday, Cyber Monday reflected a record low discount rate due to strong consumer demand as well as lower inventory. That's what we're seeing today, and that's what we've built into our fourth quarter forecast. Got it. That's helpful. My second question, just with regard to, you know, the comments you made around the color launches and maybe a more muted response to those launches on the part of your consumers. I guess I can probably lump a few questions in here together. I mean, one, have you seen this before? You know, is there a difference between how your newer or, let's say, your existing customers and new customers are reacting? Assuming you actually have played around with some price promotions, are you seeing a response when you put price promotions in place? On our color launches, you know, to be clear, we're still seeing a strong lift in both our color and our product launches, and our customer surveys are telling us that our healthcare professionals love new colors, and that it's a big purchase driver for them. You know, that being said, we're learning fast, and we're leveraging our insights to evolve our strategy there. Color is still, and is going to continue to be, a very big driver of the business. We have a lot of new innovation coming, and we're gonna take a more holistic approach to style and color launches and really integrating the stories together. I would also say, as a reminder, that color is more geared to repeat customers, and so that's where we're seeing kind of that bigger impact on repeat frequency. I'll kick it over to Trina to talk a little more about our color and product launch strategy. Thanks, Daniella. Yeah, I think if you think about our launches, right, there's really two things that we're adjusting for. We're first thing is we're really aligning our launch frequency with the demand trends that we're seeing and how frequency rates have come down a bit as healthcare professionals are spreading out their purchases over a longer period of time. The second thing that we're doing is we're evolving our launch strategy to really be more holistic and focused on product innovation. You saw that even with our launch of our cargo collection, with our launch of our Rafaela scrub jumpsuit, which is a huge hit and sold out very quickly, our packable puffer. These are some examples where we're really leaning into innovation, where our healthcare professionals are coming to us because we're bringing true functionality, and really helping them in so many aspects of their jobs. Okay. Well, I appreciate it. Thank you. Thanks, Brian. Thank you for your question, sir. Our next line of questioning comes from the line of one Edward Yruma with Piper Sandler. Your line is now open. Hey, good afternoon, guys. Thanks for taking the questions. I guess first, just to drill down a little bit on the change in accounting for the charitable contributions, could you just make us maybe understand a little bit more of how that changed and kind of the impact of the P&L, and then maybe if there's an impact going forward? As a bigger picture question, you guys put out a $1 billion bogey by 2025. I guess in context of the current environment, how do you feel about that target? Thank you. In relation to the change in our accrual methodology, this was an update that we made to our methodology to be more consistent for charitable contributions over time. It's about 190 basis points of impact, and it's something that we don't expect to repeat in the future. Trina will take your second question. As it relates to the billion-dollar target, we're still incredibly focused, working toward our goal of $1 billion, but recognize that there is a lot of volatility in the macro, and therefore, the timing of this goal is a bit more uncertain. You know, but we do see an incredible amount of opportunity in front of us, including product innovation, like what I just talked about, international, you saw the growth for the quarter, and developing our TEAMS business. From a product innovation standpoint, you know, we have a number of newer categories in outerwear, as it relates to FIGS Pro, our underscrubs category. We believe these can be incredibly large businesses in and of themselves. We also are actually launching completely new categories that our customers, our healthcare professionals, are asking for, and we're incredibly excited about that. Separately, we talked about it on the call, but we're soft launching extended sizes, 3XL to 6XL, and that's incredibly important as we're positioning ourselves to address an underserved segment of our community. Another area of growth, international. You saw it in the third quarter. We're still in the very early innings of what this will become. We're serving healthcare professionals in 13 countries, and we're learning so much about their behavior and how they wanna interact with FIGS. Our TEAMS business, we haven't really talked much about this. This is our B2B business. It's completely untapped at this stage, as we've been very focused on our D2C business. But now with our extended sizes, we're really able to build out our platform around growth for our TEAMS business. Lastly, we're continuing to evolve not only our launch strategy as I discussed, but also our marketing strategy as we're really looking to be more impactful, develop deeper connections, and really customize our messaging across channel. So, you know, we're working towards $1 billion. We're doing what's right for this brand over the long run, focusing on the development, the growth and the health of the company. We're making moves to continue to create significant and sustainable competitive advantage and continue to deliver industry-leading value creation. Thanks so much. Thank you for your question, sir. Our next line of questioning comes from the line of Adrienne Yih with Barclays. Your line is now open. Thank you very much. Good afternoon, everybody. Trina, I wanna get back to the color. You've historically done very well with the color launches, and I'm sure that you'll continue to innovate with color being a primary driver. I guess the question really is: how do you use your data to do testing on what colors are gonna uptrend and then to do more of a test and reorder, reading that demand such that in the future you'll be creating the product that, you know, the demand warrants? That's my first question. Then for Daniella, it's gonna be on the inventory. Half the business is in that core styles. On the other half of it, what portion of that is to accommodate extended sizing? And how many weeks of supply I think you said that mid next year, you think you'll have this inventory more in line with sales. Are you canceling orders? Are you reducing your open to buy? What are the actions that are being taken to get that in line? Thank you very much. Thank you. In terms of color drops, you know, we continue to see a lift in sales from our color drops. To your point, the data tells us that, you know, our customers love our color launches. As we look forward, it's really being more strategic and thoughtful about our drops. We saw it with the cargo collection. The cargo collection came in new colors, right? What we did there was we really leaned into innovation of the styles, the innovation around the silhouettes, the innovation around our functionality and the utility that those products brought to bear. As we look forward, we believe there's an opportunity to more effectively, in line with what I'm saying, more effectively merchandise the colors through taking a more holistic approach across style, color and overall product innovation, creating more aspirational messaging around our launches to drive improved sell-through and buying more shallow in terms of our launches to drive that sell-through and drive that flywheel going forward. Adrienne Yih, as it relates to inventory, you know, I think it's helpful to just remind everyone that as a uniform business, you know, our product is largely replenishment driven. Additionally, 50% is in our core offering, so it's seasonless, always in stock, and really limits our risk of obsolescence. As you can recall, we intentionally increased our weeks of supply on our core products, and we brought in color and product launches earlier due to lingering supply chain issues that we were experiencing. Additionally, a portion of our inventory did come in sooner than expected. Looking at kind of the non-core products, this is still a uniform. Historically, we have been able to move through this inventory without taking deep discounts, and we do expect our discount rates to remain roughly in line with 2019 and 2020 levels. We plan to move through some of this inventory during our Black Friday, Cyber Monday event, and we're expecting that event to look similar to 2020 in terms of discount rate. Overall, we expect to be in a better inventory position by mid 2023. Going forward, we plan to make more shallow buys for our product launches. We've reduced our POs for our core product to lower our weeks of supply in the future. We're also making enhancements to our supply chain, like diversification, which we believe will make us even more nimble and enable us to improve flow in the future. We have a strong balance sheet to support our business from a working capital perspective as we navigate these challenges in the near term. We, you know, we think we'll be able to move through this inventory balance. Thank you. That's very helpful. Best of luck. Thank you, Adrienne. Thank you for your questions, ma'am. Our next line of questioning comes from the line of Brooke Roach with Goldman Sachs. Your line is now open. Good afternoon, and thank you so much for taking our question. Trina, Daniella, I wanted to talk about your holistic thoughts around the cost structure of the business today versus where it was a few years ago and some of the investments that you're looking to make over the course of the next year. Specifically in corporate G&A and maybe excluding stock-based compensation expense. You talked a little bit about investments for product innovation and international expansion. We also have an inflationary cost environment, and many companies are taking a tighter look at corporate costs. There's been a lot of noise here, but can you talk to us about how you're thinking about the run rate G&A level of the business as you emerge from some of this near term noise, maybe second half of 2023 or into 2024, what that might run rate look like? Thanks, Brooke. We've always been focused on balancing growth and profitability, so this is a mindset that will continue for us. I think in a more uncertain macro environment, we will likely look to prioritize investments where we feel more certain about the return, where we can maximize ROI and, you know, really incorporate impacts from the macro into our near term assessments. Specifically on the G&A side, we are investing in product innovation and technology and automation. Looking over the long term, we do believe this is a line item where we can drive efficiencies. You know, making these investments at an earlier stage will set us up for more profitable growth in the future, and that's how we're really thinking about it. That's really helpful. Maybe just as a follow-up for Trina, can you provide a little bit more information on the growth opportunity that you see in your team's business? How important is that to near term growth as you enter 2023? How should we be thinking about that as a contributor as you seek to get back to your long-term algorithm of 30% growth? Yeah. I mean, I think our teams business is something that is incredibly exciting. You know, we build a first of its kind platform so that administrators could order for their entire department, their entire clinic, their entire office. We make it really seamless to do that, to order hundreds, thousands of sets of scrubs for your entire team. That experience has become more and more seamless. With extended sizes, it makes it even a bigger opportunity because I don't know another business out there where if one or two or 10 people can't fit into their uniform, the entire team, you know, won't be part of the brand. We're really excited about the future of teams. You know, in the shorter term, we're still building it out. We're really, encouraged over the long run. This is gonna be big. Thank you very much. Thank you for your questions, ma'am. Our next line of questioning comes from the line of Michael Binetti with Credit Suisse. Your line is now open. Hey, hey, guys. Thanks for taking our question here. I don't think I heard you speak about this earlier, but you mentioned that the consumer survey showed the healthcare professionals pulling back a little bit on discretionary. Within, you know, your consumer insights, have you witnessed any changes in conversion or shifting between price points on the site and can help inform you as to how you approach planning the assortment and how to be agile with what the consumer is asking for with forward inventory buys for next spring? I guess as a follow-up, I understand the demand line change in fourth quarter to date, but can you help us think a little bit more about the EBITDA margin guide? I think it's implied a little bit below 10%. I understand a lot of the deleverage is tied to lower sales expectation. What are some of the building blocks that are less tied to sales that you have line of sight to today that you can recapture for next year, be it freight or temporary warehousing costs? Michael, so looking at our consumer surveys, we mentioned that, you know, they are potentially stretching their purchases a little bit longer, but they're still really loyal to the brand. They're still really excited about FIGS. What we're seeing on the site is, as we've discussed, AOV is higher. We are driving that through both higher UPT and higher AUR. That's really driven by our lifestyle, and so we are seeing customers that when they come, they're really excited to build out their cart and spend even more with us in a transaction. Looking at adjusted EBITDA and the fourth quarter and kind of what we're expecting to continue into 2023. I think that was your second question, right? Yeah. Yes. Looking at the fourth quarter, you know, what we're seeing with gross margin is that our outlook is unchanged. We're seeing better than expected ocean and air freight rates, and that's being offset by higher promotions. Turning to selling expense, we are expecting to see higher fulfillment expense than in the third quarter because we're going to be having an entire quarter of these additional storage costs for inventory. The fact that inventory was shipped earlier than we expected, and also that storage vacancy rates were at 1%, this wasn't a cost that we had fully anticipated. Looking at marketing, we're expecting that to be just modestly above the 15%. In G&A, we are expecting to see an increase as a percent of sales due to an increase for our accrual for inventory donations and for some SOX implementation costs. What that looks like in 2023, on gross margin, we do expect the first half to be impacted by higher promotions year-over-year. We're seeing some additional margin pressure also from the product that we sell that was air freighted in 2022. This should be partially offset by easing freight rates, and we are expecting gross margin to normalize more as we get into the back half of the year and see better promotions year-over-year and also an easing of freight rates. With selling, we are expecting to see higher costs related to additional storage in the first half and a continuation of the higher shipping rates. We also expect to see some increase in our ongoing fulfillment expenses throughout the year related to initiatives that we discussed to improve flexibility and scale. We plan to maintain marketing at approximately 15% of net revenue, as we really continue to focus on being first order profitable. G&A, we will see some modest deleverage related to investments in product innovation, particularly as it relates to new categories, as well as costs related to tech enhancements and automation. While we're increasing investments in our business, we're also looking to continue to find ways to drive efficiency, and we do expect there to be some offsets as well. Like always, really continued on focusing on both growth and profitability as we continue to scale. Thanks a lot, guys. Thank you for your questions, Michael. Our next line of questions comes from the line of Rick Patel with Raymond James. Your line is now open. Thank you. Good afternoon, everyone. I was hoping you could talk about lifestyle products, maybe dig deeper there on what's working, what's not, and where you have the most conviction to drive scale. Just given the slowdown and replenishment of scrubs, what do you see as the right penetration for that segment of the business going forward? Thanks, Rick. Approximately 35% of our active customers have purchased our lifestyle products. We're incredibly pleased with the growth, 65% year-over-year. It's almost 17%. It's about 17% of our sales. You know, really excited about how we're gonna continue to build this out. The three categories that are really driving that is our outerwear business. Our packable puffer is pretty amazing, so I would check that out if I were you. Our footwear with New Balance. Our New Balance collaboration continues to be an incredible growth driver as it relates to lifestyle and finally, our underscrubs. Underscrubs isn't just, you know, the long sleeve underscrub underneath your scrub top and pant. It's kinda everything that you're wearing underneath your scrubs, from our sports bras, our leggings. You know, really looking to build that out over time. Those are kind of the areas of focus. There's a lot of other categories that we haven't even launched that will become part of our layering system. We're incredibly excited about the future of not only our scrubs business but also our lifestyle offerings. Can you also tell us what the mix of ocean freight versus air freight will be in the fourth quarter and how that compares to the year-to-date trend? Just curious also, you know, when you can get back to a more normalized cadence of leaning into ocean freight as we think about 2023. As we have seen an easing in the supply chain, we are forecasting that we will see some benefit in gross margin in the fourth quarter as it relates to better than forecasted ocean and air freight rates. We also expect to see a year-over-year benefit in air freight from lower utilization and a decrease in rates year-over-year. We're forecasting air freight expense for the fourth quarter to be around $2 million. We are seeing some benefits there. Yeah, I think looking now, we are getting into a more normalized place, and we expect that normalization to continue into next year. As a reminder, we will be incurring some air freight as we sell through the products that we brought in in 2022 into 2023. We are really minimizing the amount of air freight that we're using for receipts going forward. Thank you. All the best this holiday. Thank you. Thank you for your questions, sir. Our next line of questioning comes from the line of Lorraine Hutchinson with Bank of America. Your line is now open. Thanks. Good afternoon. You spoke a lot about right-sizing the inventory by the middle of 2023. As part of that forecasting process, can you shed some light on how you're planning first half sales? Would you expect it to be in line with current trends or are there levers you can pull to re-accelerate that growth a little bit earlier? In light of the current macro environment, it's a little too soon for us to be providing 2023 guidance, but we will talk a little about what we're seeing and what we're thinking about for next year. We do expect trends to improve from the fourth quarter, but you know, as you might assume, we are expecting a challenging first half, particularly in the first quarter, due to macro as well as efforts to move through our inventory. Going into the back half of the year, we would expect to see more strength in the fourth quarter of next year as we're lapping easier comps. I would say, you know, while the macro is more of a headwind, we're continuing to drive our business forward. We're executing on building out our non-scrub wear, continuing to dive deeper international, and also continuing to build just really deep connections with our community. We'll provide more detailed information on 2023 on our next call, but that's what we're seeing today. Thank you. Thank you for your questions. Our next line of questioning comes from the line of one Lauren Schenk with Morgan Stanley. Your line is now open. Great. Thanks. I have a few quick modeling ones, if I can. Are you seeing any increased churn of existing customers, or is it really just the frequency in AOV? Second, is there any way that you could help parse out sort of the freight versus promotional and product mix shifts in the 210 basis points in the third quarter? Just wanna clarify that October is similar to the second half of October, and then October has not gotten worse. Thank you. Looking at your first question, which I think was about churn and what we're seeing in our cohorts, we have seen a modest increase in churn among newer cohorts while our older cohorts have remained stable. Some of that is customers are showing up in reactivation. We saw a record number of reactivations in the third quarter. So a portion of that churn is healthcare professionals buying less frequency but not leaving the brand. They're coming back in month 13, 14, 15, and continuing also to spend more with us as we deliver newness in our layering system. As we look at these numbers, we're really focused on driving engagement with our customers. Through the expansion of our lifestyle offering, improved sizing and fit, through increased personalization. There's a lot that we're doing as we look at churn for the future. For your second question, I think it was around. Can you actually just repeat it really quickly? Yep. Just on the third quarter, the 210 basis points of gross margin, just how much is freight versus promotional versus product mix? Year-over-year, freight rate had a negative 200 basis points impact on gross margin. The other components of the deleverage was unfavorable sales mix shift to promotions and product mix. We saw a little bit of an offset there from better returns, driving gross margin up. Looking at October, we're not really speaking to quarter-to-date trends, but given the supply chain environment overall, we are seeing customers, you know, waiting to purchase as opposed to last year. Our forecast does reflect the trends that we saw in October, kind of continuing through the balance of the year. We're not speaking specifically to what we're seeing month-over-month. Okay. Thank you. Thank you for your questions, ma'am. Our next line of questioning comes from the line of one Bob Drbul with Guggenheim. Your line is now open. Hi. Good evening. Can you talk a little bit about the competitive landscape, you know, if you're seeing consumers really, you know, on the market or the healthcare apparel segment, like what you're seeing competitively? Can you expand a little bit more on, I know it's early on the international, but any color on, you know, which markets have performed better for you or you know, worse than expected? Thanks. Sure. From the competitive standpoint, we're not really seeing much from a change perspective. We're continuing to gain market share, and our next closest competitor from a D2C perspective is still about one-tenth our size. You know, most try to compete on lower price, but the quality of their product is just not the same, right? Customers remember quality, they don't remember price. I think we've set ourselves apart, and we're continuing to set ourselves apart from everyone else as it relates to every single thing we bring to deliver and serve this community. As it relates to international, we're really just being super encouraged by the growth, 49%, year-over-year. We've seen a lot of healthcare professionals really, you know, coming to the brand. Canada and U.K. are a huge focus of ours. We've seen that those two countries really drive that growth in a bigger way as we are building up the other newer countries we've entered. Couldn't be more excited about international and what we'll continue to do there. We're localizing the experience. We're bringing translations. We're really targeting each country with localized marketing efforts. You know, as we become a truly global brand, you know, we're excited to serve the entire global healthcare community. Great. Thank you very much. Thank you for your question, sir. Our next line of questioning comes from the line of one Dana Telsey with Telsey Advisory Group. Your line is now open. Hi, good afternoon, everyone. As you seek to adjust the inventory levels, what channels are you gonna reduce inventory through? I know you've done some things in L.A. sometimes, and you have an event to get rid of the inventory. How do you see that? How do you see disposing of the inventory? Second, on the fulfillment enhancements that you're making, what should we see and over what time period, and is there a specific cost allocated to that? I just have a follow-up. Thank you. Looking at our inventory, you know, we really don't expect discount rate to be meaningfully different than 2019, 2020 levels. We do think we can move through this inventory at a discount rate that looks like our historical levels. We have multiple channels and events through which to move inventory. We have our Black Friday, Cyber Monday event that's coming up. We also are planning to launch an evergreen sales section to our website to drive just more consistent performance between launch and non-launch days. This feature will, you know, also enable customers to come back and purchase their favorite prior colors on our sales tab at any time. We can move through inventory similarly through Amazon or our B2B business. We're evaluating all of our channels and, you know, determining the best way to approach it and meet the customer where they are with the colors that they're, you know, really excited to see. I'm sorry. Can you repeat your second question? Fulfillment. You talked about making enhancements to fulfillment. What are you doing, and what's the timeframe to complete what you want? Is there a cost to that that's either permanent, that's part of your margin, a part of the margin structure, or some transitory that goes away after you implement it? On fulfillment, you know, we're really kind of in the process of evaluating this right now. We will be giving a more fulsome update on our next call. We're looking to continue to build to drive more flexibility, to improve efficiency, and to ensure that we can really provide the best experience to our customers. We are expecting this to come at a higher rate, but we do think that it's the best thing for the business over time. We don't have the specifics today, but we are planning to do an update on our next call. Okay. Just lastly, you've added some new talent, whether it's in merchandising or in marketing. Any updates to the processes that they're bringing or the opportunity that they foresee, and Trina, how you look at working with them in order to move the ball forward? Yes. I mean, this is really exciting. We recently brought on Sunil Kaki as our chief marketing officer. He comes from, you know, an extensive background from Amazon, Intuit, Beachbody, and really brings not only digital knowledge and know-how, but also really has a lot of, you know, deep background in brand building and community engagement. We couldn't be more excited about him joining us. I think what you're gonna see over time is really us capitalize on a larger opportunity to align our creative, align our messaging with the appropriate channel and the appropriate audience. This is something that we are actively implementing today, and we couldn't be more excited about in the future. Thank you. Thank you for your questions, ma'am. Our last question comes from the line of John Kernan with Cowen. Your line is now open. Great, thanks. Just wanted to go back to some of the points on fulfillment and distribution. It looked like selling expenses per order was up pretty significantly in the third quarter. Any specific dynamics related to that, and how should we think about selling expense as we get through into Q4 next year? Fulfillment expense was higher in the third quarter because of these additional storage costs for our inventory. As we said, you know, inventory shipped earlier than planned, and storage vacancy rates were at less than 1%, so it was more costly than anticipated to store this inventory. Looking into the fourth quarter, we're expecting to have a full quarter of these additional costs, and so we would expect that to continue to remain pressured. Probably looking into the first half of 2023, we'll see some pressure from this additional storage line item. Understood. Thanks. Just one more question. On the inventory, it's up about $100 million on a cost basis on the balance sheet, about 142% year-over-year. If we back into the inventory turn, it's a little over 1 time. How do we think about DSOs and inventory turn as we get into next year? We are expecting to be in a better inventory position by mid-2023 on a turn and a days perspective. You know, as a reminder, our product is largely replenishment driven. It's a uniform, so we would expect to have higher inventory days than a traditional apparel company. We wanna make sure that we have this product. It's always in stock, always in style, and we can serve our healthcare community. We're actively making updates to bring that down, and we are expecting it to be in a better position by mid-2023, but we would expect to be higher than, you know, a traditional apparel company. Understood. Thank you. That's what. Thank you. Thank you for your questions, sir. I think we got a few questions from our shareholder community through the Say platform. I really just want to address a key topic that came up through the platform around the integrity of FIGS and how we are addressing that. I think you know, a lot of the noise around this really stems from a recent litigation with a company called SPI. SPI has spent the last four years spreading lies and falsehoods about our company and myself personally, my co-founder, Heather Hasson, personally. You know, I think over the last four years, we've really done a good job about putting blinders on and just focusing on growing our business, focusing on serving our community. I'm really proud to say that after four years, it's a profound feeling to finally have our day in court. We were in, you know, federal court over the last three weeks, where finally the truth came out. After three weeks of trial, the jury unanimously found in our favor on every single issue. They found that we did nothing wrong. As painful as this experience was, I'm glad that justice was served. I'm also what it showed us is that it's just. It showed us how much FIGS has revolutionized this industry, and we're not stopping here. We are gonna continue to revolutionize the industry and change the game for healthcare professionals. That is why we wake up every single day, to show up and serve. That's what we're continuing to do. Thank you all for joining us. Thank you all for joining our third quarter call. We look forward to speaking with you again soon. With that, we will conclude today's FIGS third quarter fiscal 2022 earnings conference call. Thank you for your participation.